Re:Humira’s Drug Formula: Start at a High Price, Go Higher
by kgwgk on Monday January 08, 2018 @06:24AM
(#16096041)
> Once a blockbuster like Humira happens, it seems to kill off the field.
Actually what kills the field is effective drugs losing exclusivity. While the best-in-class treatments have patent protection R&D investment in the same therapeutic category is less risky than when you have to come up with something much better than the unexpensive generic/biosimilar already available.
Actually what kills the field is effective drugs losing exclusivity. While the best-in-class treatments have patent protection R&D investment in the same therapeutic category is less risky than when you have to come up with something much better than the unexpensive generic/biosimilar already available.